...that the x-ray was discovered purely by accident? When German physicist Wilhelm Konrad von Roentgen was experimenting with cathode rays in 1895, he put an activated Crookes tube in a book and went out to lunch. When he returned, he discovered that a key that had also been placed in the book showed up as an image on the developed film!
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7432302 | Composition containing polyamine transport inhibitor and use thereof Proliferative cutaneous disease states or conditions are treated by administering a polyamine transport inhibitor R-X-L-polyamine wherein R is a straight or branched C10-50 saturated or unsaturated aliphatic, carboxyalkyl... | 10/07/2008 |
| 7414152 | N-substituted p-menthane carboxamides Cooling compounds are provided having the formula: wherein, m is 0 or 1, Y and Z are selected independently from the group consisting of H, OH, C1-C4 straight or branched alkyl, and a C1-C4 straight or branched alkoxy, X is... | 08/19/2008 |
| 7208510 | Fungicidal combinations of active substances The present invention relates to fungicidally active compound combinations of a fluorobenzothiazole derivative of the formula (I) and at least one of the compounds listed in the disclosure. ... | 04/24/2007 |
| 7205331 | Fungicidal carboxamides Compounds of Formula I are disclosed which are useful as fungicides wherein X is —O—, —CH(R11)—or ═C(R11 | 04/17/2007 |
| 7115593 | Fungicidal combinations of active substances The present invention relates to active compound combinations of a fluorobenzo-thiazole of the formula (I) and at least one of the compounds listed herein. The active compound combinations of the present inventio... | 10/03/2006 |
| 7074833 | Use of the (1S,2R) enantiomer of milnacipran for the preparation of a drug A method for treating or preventing a disorder or a condition by double inhibition of serotonin (5-HT) and noradrenaline (NA) reuptake in a subject in need thereof, while limiting the risks of cardiovascular disturbances and/or organ and/or tissue toxicity, comprisi... | 07/11/2006 |
| 7053071 | Induction of apoptosis in cancer cells The present invention provides compounds that are inducers or inhibitors of apoptosis or apoptosis preceded by cell-cycle arrest. In addition, the present invention provides pharmaceutical compositions and methods for treating mammals with leukemia or other forms of... | 05/30/2006 |
| 7038085 | Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof The present invention relates generally to the enantiomers of para-hydroxy-milnacipran or congeners thereof. Biological assays revealed that racemic para-hydroxy-milnacipran is approximately equipotent in inhibiting serotonin and norepinephrine uptake (IC50 | 05/02/2006 |
| 7034057 | Compounds for the treatment of inflammatory disorders This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, TNF-α or combi... | 04/25/2006 |
| 7005452 | Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug The present invention concerns the use of a mixture of enantiomers enriched in the dextrogyral enantiomer of milnacipran and/or of at least one of its metabolites, as well as their pharmaceutically-acceptable salts, for the preparation of a drug intended to prevent ... | 02/28/2006 |
| 6995285 | ABCA-1 elevating compounds The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery dis... | 02/07/2006 |
| 6960687 | Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and CNS activity, and method for their preparation New derivatives of N-Hydroxyalkyl-tetramethylcyclopropane carboxamide, pharmaceutical compositions thereof, methods for their preparation, and use thereof for the treatment of epilepsy, neurological, affective and psychotic disorders and for the treatment of pain an... | 11/01/2005 |
| 6872751 | Composition and method for augmenting or restoring the production of fetal protein in patient in need thereof The present invention relates to methods for prevention and/or treatment of diseases or conditions caused by deficiency in the adult isoform of a given protein wherein said method comprises administering to a patient in need thereof a composition containing NO or at... | 03/29/2005 |
| 6730635 | Microcapsule suspensions The invention relates to microcapsule suspensions containing (A) a particulate disperse phase of microcapsules comprising: (1) sleeves that are reaction products of mixtures of toluylene diisocyanate and 4,4′-methylenebis-(cyclohexyl isocyanate) with... | 05/04/2004 |
| 6703379 | Benzene derivatives and pharmaceutical use thereof The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammat... | 03/09/2004 |
| 6683114 | Treatment of psoriasis Norepinephrine reuptake inhibitors are used to treat psoriasis.... | 01/27/2004 |
| 6670400 | Phenoxyethylamine derivatives having high affinity for the 5-HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives Phenoxyethylamine derivatives of general formula (I) having high affinity for the 5-HT1A receptor, methods for preparing same, pharmaceutical compositions containing said derivatives, and their use, in particular as gastric acid secretion inhib... | 12/30/2003 |
| 6602911 | Methods of treating fibromyalgia The present invention provides a method of treating fibromyalgia syndrome (FMS), chronic fatigue syndrome (CFS), and pain in an animal subject. The method generally involves administering a therapeutically effective amount of a dual serotonin norepinephri... | 08/05/2003 |
| 6441044 | Cycloalkyl carboxylic acid amides, their production and their use as fungicides in agriculture The present invention relates to cycloalkylcarboxamides of formula I ##STR1## where: A is optionally substituted C3 -C6 -cycloalkyl; Alk is straight-chain or branched C1 -C6 -alkylene; R1 is optionally substitu... | 08/27/2002 |
| 6313163 | 2,4-pentadienoic acid derivatives having retinoid-like biological activity Compounds of formula 1 ##STR1## wherein Z is selected from the group consisting of the radicals shown in Formula 2 and in Formula 3, ##STR2## Y is cyclopropyl optionally substituted with one or two R4 groups, the divalent Y radical being s... | 11/06/2001 |
| 6262104 | Diarylalkenylamine derivatives Compounds, or solvates or salts thereof, of formula (I): ##STR1## selective delta opioid agonists and antagonists and may be of therapeutic utility as analgesics, immunosuppressants to prevent rejection in organ transplant and skin graft, anti-allergic an... | 07/17/2001 |
| 6262091 | Process and agents for controlling harmful fungi Compositions for controlling harmful fungi, containing in a solid or liquid carrier a) at least one p-hydroxyaniline derivative of the formula I ##STR1## b) at least one amide compound of the formula II A--CO--NR8 --R9 (II) where the sub... | 07/17/2001 |
| 6251947 | Fungicidal carboxamides ##STR1## Compounds of Formula (I) are disclosed which are useful as fungicides, wherein Q is: (Q-1) or (Q-2), Z is (Z-1); (Z-2); (Z-3) or (Z-4); X is --O--, --CH(R11)-- or .dbd.C(R11)--; R1 is H or C1 -C | 06/26/2001 |
| 6235789 | Benzocycloalkene compounds, their production and use A compound of the formula ##STR1## wherein R1 and R2 are H, a hydrocarbon group or a heterocyclic group, or R1 and R2 are combinedly a spiro ring; R3 is a hydrocarbon group, a substituted amino group,... | 05/22/2001 |
| 6214869 | Heterocyclic cis cyclopropane derivatives as melatonergic agents There is provided a novel series of cis cyclopropane compounds of Formula I ##STR1## wherein R1, R2, R3, R4, X, Y, Z and m are as defined herein which bind to the human melatonin receptor and therefore are useful ... | 04/10/2001 |
| 6143789 | Naphthalene compounds Compound of formula (I): ##STR1## wherein: T represents alkylene, A and B together form a naphthalene, dihydronaphthalene, or tetrahydronaphthalene group, R represents hydrogen, hydroxy, R' or OR', R' being as defined in the description, G1 | 11/07/2000 |
| 6090854 | Aryloxyanilides and related compounds There is provided novel aryloxyanilides and related compounds of the formula ##STR1## wherein R1 is --OR, --CO2 R, or halogen with R being C1-4 alkyl; R2 is R, cyclopropyl, C2-4 alkenyl or --CH | 07/18/2000 |
| 6028112 | Spirocyclopropyl fluorenes as melatonergic agents There is provided novel spirocyclopropyl fluorene derivatives having the general Formula I ##STR1## wherein R, R1 and X are as defined herein which are useful as melatonergic agents.... | 02/22/2000 |
| 5965621 | Methods and compositions for reducing or maintaining body weight in a mammal A method for reducing or maintaining the level of adipose tissue formation in a mammal includes the step of administering a pantethine composition to the mammal in an amount and for a period of time sufficient to achieve a desired body weight. Composition... | 10/12/1999 |
| 5962413 | Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor Dysmenorrhea, disfunctional uterine bleeding, preterm labor and postpartum labor in female mammals are treated by inhibiting uterine contractility by administering thereto a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in comb... | 10/05/1999 |
| 5929119 | Fungicidal composition A composition which is suitable for controlling fungal pests, comprising conventional additives and an effective amount of a p-hydroxyaniline derivative of the general formula I ##STR1## where the substituents have the following meanings: R1 | 07/27/1999 |
| 5925674 | Cycloalkylcarboxanilides This invention relates to cycloalkylcarboxanilides of the formula ##STR1## which are used to combat pests.... | 07/20/1999 |
| 5922771 | Benzocycloalkene compounds, their production and use A compound of the formula ##STR1## wherein R1 and R2 independently represent H or an optionally substituted hydrocarbon group; R3 represents an optionally substituted hydrocarbon group; R4 represents H or a... | 07/13/1999 |
| 5885621 | Treatment of a hemoglobinopathy Disclosed are methods for treating a patient identified as having a hemoglobinopathy that is characterized by a reduced affinity of hemoglobin for oxygen. The methods involve providing gaseous nitric oxide and/or carbon monoxide for (i) inhalation by the ... | 03/23/1999 |
| 5880157 | Derivatives of tetramethylcyclopropane The present invention relates to derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid (TMCA) of general formula (I), ##STR1## wherein R is lower alkyl group (C1 -C6), an aryl group, an aralkyl group or an amide of... | 03/09/1999 |
| 5780512 | Alkylated (hetero) cyclic compounds The invention relates to a compounds selected from these of formula (I): ##STR1## in which: R1, R2, R3 and A are as defined in the description, and a medicinal product containing the same useful for treating a melaton... | 07/14/1998 |
| 5763466 | Fungicidal active compound combinations A novel fungicidal composition comprising a fungicidally effective amount of a combination consisting of (i) N-1-(4-chloro-phenyl)-ethyl!-2,2-dichloro-1-ethyl-3-methyl-cyclopropaneca rboxamide of the formula ##STR1## and (ii) (A) a triazole de... | 06/09/1998 |
| 5753709 | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics Certain N-acyl 2-aryl cyclopropylmethylamine derivatives are useful as melatonergic agents.... | 05/19/1998 |
| 5736578 | Ethylamido fluorenes and improved method of making same Novel substituted fluorene compunds of Formula I are active as melatonergic agents: ##STR1## wherein: X=H, halogen, OH or OZ; Z=C1-6 alkyl; --(CH2)m --CF3 (m=0-2); CD3 ; or ##STR2## n=1 or 2... | 04/07/1998 |
| 5696150 | Fungicidal active compound combinations A novel fungicidal composition comprising a fungicidally effective amount of a combination consisting of (i) N-1-(4-chloro-phenyl)-ethyl!-2,2-dichloro-1-ethyl-3-methyl-cyclopropaneca rboxamide of the formula ##STR1## and (ii) (A) a triazole de... | 12/09/1997 |